DGAP-News: myoscience Named Winner of the 2014 Red Herring

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: myoscience Named Winner of the 2014 Red Herring Top 100 North America Award

DGAP-News: myoscience / myoscience Named Winner of the 2014 Red Herring Top 100 North America Award 22.05.2014 / 00:39 --------------------------------------------------------------------- REDWOOD CITY, Calif., 2014-05-22 00:38 CEST (GLOBE NEWSWIRE) -- California based myoscience, inc., makers of the revolutionary iovera* system for treatment of peripheral nerves, has been named a winner of the prestigious Red Herring 2014 Top 100 North America Award. As a winner, myoscience joins a short list that honors the year's most promising private companies. Starting from a field of over 3,000 candidates, myoscience was selected as a Top 100 winner by Red Herring. Award winners were selected using a rigorous evaluation process that included both quantitative and qualitative criteria, such as financial performance, technological innovation and intellectual property, management quality, business model, customer footprint and market penetration. Myoscience's groundbreaking iovera* treatment utilizes the body's natural response to cold to deliver immediate results for both therapeutic and aesthetic applications. The iovera* system is FDA cleared for the treatment of pain in the United States and is approved in the European Union and Canada for the treatment of wrinkles. 'In 2014, selecting the top 100 achievers was by no means a small feat,' said Alex Vieux, publisher and CEO of Red Herring. 'In fact, we had the toughest time in years because so many entrepreneurs had crossed significant milestones so early. But after much thought, rigorous contemplation and discussion, we narrowed our list down from all the candidates across North America to the top 100 winners. We believe myoscience embodies the vision, drive and innovation that define a successful entrepreneurial venture. Myoscience should be proud of its accomplishment, as the competition was very strong.' 'We are proud of our team, grateful to our investors, and very honored to have been selected for this highly coveted distinction,' said myoscience CEO Clint Carnell. 'This selection further validates the hard-work and dedication of our team in bringing this remarkable platform technology to patients around the world.' ABOUT MYOSCIENCE Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold Therapy, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the iovera:o system. The iovera:o system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com. (c) 2014 myoscience. All rights reserved. iovera* and Focused Cold Therapy are trademarks of myoscience. MKT-0250 REV A CONTACT: 1600 Seaport Blvd., Ste. 450 / Redwood City, CA Tel: 650.474.2600 / iovera.com MEDIA RELATIONS Jay Patel / jay.patel@hypertonic.com News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 22.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: myoscience United States ISIN: US9902131674 End of News DGAP News-Service --------------------------------------------------------------------- 269921 22.05.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 200

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 235

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 185

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 185

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 281

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 312

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Community in Shock After Fatal Bakersfield Shooting

Updated Category News Views 158

The Ripple Effect of Tragedy Grief has a way of shaking a community down to its core—especially when the loss emanates from such senseless violence as the shooting death of 17-year-old Levi Brown. This wasn't just a tragic occurrence at a Friday night football game in Bakersfield; it was a visceral crack in the perceived safety of community events. Levi's Legacy and...

Continue Reading
Clarins Dazzles Austin with Skin Longevity Event

Updated Category News Views 222

Clarins Takes Austin by Storm Under the vast Austin sky, something remarkable unfolded as Clarins transformed the scene with a flashy rooftop affair that screamed innovation and elegance. They weren’t just showing off fancy bottles of beauty potion; they were stirring the pot, merging science with a splash of high-end glitz. This wasn’t just another product pitch—it...

Continue Reading

Top 5 Most Recently Viewed Articles

CSX CFO to Discuss Strategic Insights at Major Conference

Updated Category News Views 92

CSX's Leadership in Transportation Conference CSX Corp. Executive Vice President and Chief Financial Officer, Sean Pelkey, is set to engage with key industry stakeholders at the upcoming UBS Global Industrials and Transportation Conference. This important event is scheduled to take place on a Wednesday morning, a date that promises significant opportunities for insights...

Continue Reading
Maximizing Dividend Income from Kohl’s Stock Effectively

Updated Category News Views 84

Understanding Dividend Income from Kohl's Stock Kohl’s Corporation (NYSE: KSS) is preparing to share its fourth-quarter financial results. Investors and analysts alike are keenly anticipating this release. What Are Analysts Expecting? Analysts have forecasted a decrease in earnings, projecting the company to report earnings of 77 cents per share, a decline from $1.67...

Continue Reading
Coca-Cola Welcomes Netflix's Bela Bajaria to Its Board Team

Updated Category News Views 203

Introduction of Bela Bajaria to Coca-Cola's Board The Coca-Cola Company recently welcomed Bela Bajaria, the Chief Content Officer of Netflix, to its Board of Directors, reflecting a significant strategic move. The election emphasizes Coca-Cola’s commitment to integrating diverse perspectives into its leadership. The Experience of Bela Bajaria Bela Bajaria’s...

Continue Reading
Eric Schwartz Takes the Helm as President of Loeb

Updated Category News Views 143

Eric Schwartz Takes the Helm at Loeb Seasoned Leader to Drive Innovation, Growth, and Team-First Culture Loeb has announced an exciting new chapter in its journey as Eric Schwartz has been appointed President. In this pivotal role, Schwartz will steer the company's strategic direction, embracing its long-standing tradition of innovation and aiming for growth across...

Continue Reading
Opportunity for Bumble Inc. Investors to Join Class Action Suit

Updated Category News Views 75

Join the Class Action Lawsuit Against Bumble Inc. Attention, Bumble Inc. investors! If you've experienced significant losses in your investments, you may be entitled to participate in a class action lawsuit initiated by the well-established law firm, Bronstein, Gewirtz & Grossman, LLC. This lawsuit addresses the grievances of shareholders who acquired Bumble securities...

Continue Reading